Notice of Results
24 February 2020
Instem plc
("Instem" or the "Company")
Notice of Results
Instem plc (AIM: INS), a leading provider of IT solutions to the global life sciences market, will announce results for the year ended 31 December 2019 on Monday 30 March 2020.
Analyst Presentation
Management will be hosting a presentation on the day of the results at 10.30am at the offices of Walbrook PR, 4 Lombard Street, London, EC3V 9HD. Analysts wishing to attend the presentation should register their interest by emailing instem@walbrookpr.com or by telephoning 020 7933 8780.
For further information, please contact:
Instem plc | www.instem.com |
Phil Reason, CEO | +44 (0) 1785 825600 |
Nigel Goldsmith, CFO | |
N+1 Singer (Nominated Adviser & Broker) | +44 (0) 20 7496 3000 |
Peter Steel / Alex Bond (Corporate Finance) | |
Rachel Hayes (Corporate Broking) | |
Wallbrook Financial PR | Tel: +44 (0) 20 7933 8000 |
Nick Rome | instem@walbrookpr.com |
Tom Cooper | |
Nicholas Johnson |
About Instem
Instem is a leading provider of IT solutions & services to the life sciences market delivering compelling solutions for Study Management and Data Collection; Regulatory Solutions for Submissions and Compliance; and Informatics-based Insight Generation.
Instem solutions are in use by customers worldwide and enable our clients to bring life enhancing products to market faster.
Instem's portfolio of software solutions increases client productivity by automating study-related processes while offering the unique ability to generate new knowledge through the extraction and harmonisation of actionable scientific information.
Instem supports over 500 clients through offices in the United States, United Kingdom, France, Japan, China and India.
To learn more about Instem solutions and its mission, please visit instem.com.